NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs031180043

Registered date:27/11/2018

EMPYREAN Study

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedtype 2 diabetes mellitus
Date of first enrollment22/01/2018
Target sample size134
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Empagliflozin 10mg/day or Sitagliptin 50mg/day

Outcome(s)

Primary OutcomeChange in LF/HF at 24 weeks after the treatment
Secondary OutcomeBody Height, Body Weight, BMI, HbA1c

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 75age old
GenderBoth
Include criteriaType 2 DM (HbA1c 6.5-10%) . HbA1c 7.0-10% for patients who are taking sulfonylurea/glinides.
Exclude criteriaTreated with Insulin, GLP-1 analogue, SGLT2/DPP4 inhibitors

Related Information

Contact

Public contact
Name Hirohiko Motoki
Address Asahi 3-1-1, Matsumoto, Nagano, JAPAN Nagano Japan 390-8621
Telephone +81-263-37-3486
E-mail hmotoki@shinshu-u.ac.jp
Affiliation Department of Cardiovascular Medicine, Shinshu University School of Medicine
Scientific contact
Name Kouichiro Kuwahara
Address Asahi 3-1-1, Matsumoto, Nagano, JAPAN Nagano Japan 390-8621
Telephone +81-263-37-3486
E-mail kkuwah@shinshu-u.ac.jp
Affiliation Department of Cardiovascular Medicine, Shinshu University School of Medicine